Oncology Infusion Pharmacist — Therapeutic Optimization

Dana-Farber Cancer Institute; Georgia; In loco; USD 115.000 - 153.000; Tempo pieno

Descrizione del lavoro

The Infusion Pharmacist I at Dana-Farber Cancer Institute is responsible for overseeing the preparation, compounding, order verification, and dispensing of pharmaceuticals in oncology and sterile compounding settings. This role focuses on optimizing drug therapy by identifying and preventing drug-related problems and adverse events.

Located in Boston, the institute emphasizes inclusive care, advances in cancer treatment, and collaboration with Harvard Medical School-affiliated hospitals.

Competenze

• Bachelor of Science in Pharmacy or Doctor of Pharmacy from an accredited college.
• 1 year hospital/ambulatory care/sterile compounding, or 3 years retail pharmacist experience.
• Oncology pharmacy experience preferred.

Mansioni

• Oversees preparation, compounding, order verification, and dispensing of pharmaceuticals, including sterile products and chemotherapy.
• Evaluates medication orders for completeness and appropriateness; clarifies with providers/nurses as needed.
• Performs quality control on orders and prepared medications; maintains logs and inventory checks.
• Reviews investigational protocols against orders for compliance before dispensing.
• Supervises pharmacy technicians and students as assigned.
• Performs other duties and projects as needed.

Conoscenze

Effective communication

Team collaboration

Tech literacy

Prioritization

Problem solving

Critical thinking

Formazione

Bachelor of Science in Pharmacy

Doctor of Pharmacy

Descrizione del lavoro

The Infusion Pharmacist I at Dana-Farber Cancer Institute is responsible for overseeing the preparation, compounding, order verification, and dispensing of pharmaceuticals in oncology and sterile compounding settings. This role focuses on optimizing drug therapy by identifying and preventing drug-related problems and adverse events.

Located in Boston, the institute emphasizes inclusive care, advances in cancer treatment, and collaboration with Harvard Medical School-affiliated hospitals.